Moreover, NS3 promotes liver disease progression by stimulating hepatic fibrosis in HCV-infected chimeric mice, which can be attenuated by treatment with an anti-NS3 antibody [37]. The gene discussed is KRAS; the disease is Hepatic fibrosis.